Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Dermatology
•
General Dermatology
How do you determine if a pyoderma gangrenosum lesion is “burned out"?
What changes do you make to your treatment approach to adapt to this altered disease state?
Answer from: at Community Practice
The first sign is it becomes much less exudative.
Sign in or Register to read more
24584
Related Questions
How would you manage a patient with nonspecific clinical symptoms and pathology consistent with spongiotic and psoriasiform dermatitis other than oral JAK inhibitors?
What concentration of TCA is typically used to treat porokeratosis on the arms and legs?
What work up do you pursue for a thorough evaluation in patients that present with a potential diagnosis of dermatitis artefacta?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
What is your treatment approach for hidradenitis suppurativa?
What role does oral roflumilast play in dermatology?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?